4//SEC Filing
Babiss Lee 4
Accession 0001498376-11-000001
CIK 0001003124other
Filed
Feb 24, 7:00 PM ET
Accepted
Feb 25, 3:45 PM ET
Size
11.0 KB
Accession
0001498376-11-000001
Insider Transaction Report
Form 4
Babiss Lee
Exec. VP - Global Lab Services
Transactions
- Award
Stock Options (to buy)
2011-02-23+30,000→ 30,000 totalExercise: $27.27From: 2012-02-23Exp: 2021-02-23→ Common Stock (30,000 underlying) - Award
Restricted Stock Units
2011-02-23+10,000→ 10,000 total→ Common Stock (10,000 underlying)
Holdings
- 46,578
Stock Options (to buy)
Exercise: $20.45From: 2011-02-25Exp: 2020-02-25→ Common Stock (46,578 underlying) - 15,000
Stock Options (to buy)
Exercise: $26.64From: 2011-06-17Exp: 2020-06-17→ Common Stock (15,000 underlying)
Footnotes (4)
- [F1]These options vest in three equal increments on 2/23/12, 2/23/13 and 2/23/14.
- [F2]Each restricted stock unit (RSU) represents a contingent right to receive one share of PPDI common stock. The RSUs vest in three equal installments on 2/23/12, 2/23/13 and 2/23/14. Unvested RSUs are forfeited at termination of employment.
- [F3]These options vest in three equal increments on 6/17/11, 6/17/12 and 6/17/13.
- [F4]These options vest in three equal increments on 2/25/11, 2/25/12 and 2/25/13.
Documents
Issuer
PHARMACEUTICAL PRODUCT DEVELOPMENT INC
CIK 0001003124
Entity typeother
Related Parties
1- filerCIK 0001498376
Filing Metadata
- Form type
- 4
- Filed
- Feb 24, 7:00 PM ET
- Accepted
- Feb 25, 3:45 PM ET
- Size
- 11.0 KB